COGNITION THERAPEUTICS INC (CGTX:NASDAQ)

$0.9235 -0.0259 (-2.728%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 69

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed COGNITION THERAPEUTICS INC (CGTX:NASDAQ) News Sources

Hantavirus Outbreak Shows Need for Broad-Spectrum Antiviral Drugs

12-05-2026

yahoo.com

Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

14-05-2026

yahoo.com

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

21-05-2026

yahoo.com

Cognition Therapeutics Participating in Upcoming Investor Conferences

01-06-2026

yahoo.com

Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies?

02-06-2026

yahoo.com

Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045

16-06-2026

yahoo.com

Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes

24-06-2026

yahoo.com

Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX)

24-06-2026

advfn.com

Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%

24-06-2026

stocktwits.com

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit

13-07-2026

yahoo.com

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) Sentiment Trend

0 25 50 75 100 8 61 63 83 89 54 82 89 84 78 12-05-2026 14-05-2026 21-05-2026 01-06-2026 02-06-2026 16-06-2026 24-06-2026 13-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) FAQs

toggle

What is the current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The current price of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is $0.9235.


toggle

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is $-0.0259.


toggle

COGNITION THERAPEUTICS INC (CGTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of COGNITION THERAPEUTICS INC (CGTX:NASDAQ) since the previous trading day is -2.728%.


toggle

What is the most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The most recent average sentiment score for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is 69 out of 100.


toggle

What is the most recent average sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ)?

The most recent sentiment for COGNITION THERAPEUTICS INC (CGTX:NASDAQ) is .


SEC-8K** Filing Available For COGNITION THERAPEUTICS INC (CGTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.